Glash Vista

Glash Vista is a topical cutaneous solution containing 0.03% bimatoprost, specifically indicated for the treatment of hypotrichosis of the eyelashes (inadequate or not enough eyelashes). Developed by Allergan (now part of AbbVie), it was the first pharmaceutical product in Japan approved for this indication. The drug is a synthetic prostamide analog that mimics naturally occurring prostaglandins. It works by increasing the duration of the anagen (growth) phase of the eyelash hair cycle and expanding the size of the hair follicle bulb, resulting in longer, thicker, and darker eyelashes. It is applied once daily to the skin of the upper eyelid margin at the base of the eyelashes.

Brand names

Glash VistaLatisse

Other names

Bimatoprost cutaneous solution 0.03%Bimatoprost 0.03%